141 related articles for article (PubMed ID: 34274984)
1. Identifying Patients Who May Benefit from Liver Resection Compared to Living Donor Liver Transplantation for Hepatocellular Carcinoma Using
Yoh T; Seo S; Taura K; Hamaguchi Y; Ogiso S; Fukumitsu K; Ishii T; Hata K; Kaido T; Nakamoto Y; Uemoto S
World J Surg; 2021 Nov; 45(11):3395-3403. PubMed ID: 34274984
[TBL] [Abstract][Full Text] [Related]
2. Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
Hsu CC; Chen CL; Wang CC; Lin CC; Yong CC; Wang SH; Liu YW; Lin TL; Lee WF; Lin YH; Chan YC; Wu YJ; Eng HL; Cheng YF
Transplantation; 2016 Sep; 100(9):1925-32. PubMed ID: 27306534
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.
Lee SD; Kim SH; Kim YK; Kim C; Kim SK; Han SS; Park SJ
Transpl Int; 2013 Jan; 26(1):50-60. PubMed ID: 23106431
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study.
Ling LL; Hsu CC; Yong CC; Elsarawy AM; Chan YC; Wang CC; Li WF; Lin TL; Kuo FY; Cheng YF; Lin LM; Chen CL; Lin CC
Int J Surg; 2019 Sep; 69():124-131. PubMed ID: 31386913
[TBL] [Abstract][Full Text] [Related]
5. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
Takada Y; Kaido T; Shirabe K; Nagano H; Egawa H; Sugawara Y; Taketomi A; Takahara T; Wakabayashi G; Nakanishi C; Kawagishi N; Kenjo A; Gotoh M; Toyoki Y; Hakamada K; Ohtsuka M; Akamatsu N; Kokudo N; Takeda K; Endo I; Takamura H; Okajima H; Wada H; Kubo S; Kuramitsu K; Ku Y; Ishiyama K; Ohdan H; Ito E; Maehara Y; Honda M; Inomata Y; Furukawa H; Uemoto S; Yamaue H; Miyazaki M; Takada T;
J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):49-57. PubMed ID: 27806426
[TBL] [Abstract][Full Text] [Related]
6. Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.
Lee SD; Kim SH; Kim SK; Kim YK; Park SJ
Transplantation; 2015 Oct; 99(10):2142-9. PubMed ID: 25905981
[TBL] [Abstract][Full Text] [Related]
7. Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria.
Bhangui P; Saigal S; Gautam D; Piplani T; Choudhary N; Chaudhary R; Yadav S; Thiagarajan S; Rastogi A; Saraf N; Nundy S; Soin AS
Liver Transpl; 2021 Feb; 27(2):209-221. PubMed ID: 33253492
[TBL] [Abstract][Full Text] [Related]
8. Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.
Hong G; Suh KS; Suh SW; Yoo T; Kim H; Park MS; Choi Y; Paeng JC; Yi NJ; Lee KW
J Hepatol; 2016 Apr; 64(4):852-9. PubMed ID: 26658686
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.
Min JH; Kim SH; Hwang JA; Hyun SH; Ha SY; Choi SY; Kim SW; Kim HS
Eur Radiol; 2021 Jun; 31(6):3649-3660. PubMed ID: 33211142
[TBL] [Abstract][Full Text] [Related]
10. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
[TBL] [Abstract][Full Text] [Related]
11. Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation.
Kang YK; Choi JY; Paeng JC; Kim YI; Kwon HW; Cheon GJ; Suh KS; Kwon CHD; Lee DS; Kang KW
Eur Radiol; 2019 Nov; 29(11):6009-6017. PubMed ID: 31115626
[TBL] [Abstract][Full Text] [Related]
12. Impact of metabolic indices of
Bauschke A; Altendorf-Hofmann A; Brückner L; Drescher R; Freesmeyer M; Settmacher U
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1401-1410. PubMed ID: 35451699
[TBL] [Abstract][Full Text] [Related]
13. Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.
Dai WC; Chan SC; Chok KS; Cheung TT; Sharr WW; Chan AC; Tsang SH; Fung JY; Poon RT; Fan ST; Lo CM
HPB (Oxford); 2014 Aug; 16(8):749-57. PubMed ID: 24467735
[TBL] [Abstract][Full Text] [Related]
14. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
[TBL] [Abstract][Full Text] [Related]
15. Primary Living-donor Liver Transplantation Is Not the Optimal Treatment Choice in Patients With Early Hepatocellular Carcinoma With Poor Tumor Biology.
Park MS; Lee KW; Kim H; Choi YR; Hong G; Yi NJ; Suh KS
Transplant Proc; 2017 Jun; 49(5):1103-1108. PubMed ID: 28583536
[TBL] [Abstract][Full Text] [Related]
16. Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.
Kornberg A; Küpper B; Tannapfel A; Büchler P; Krause B; Witt U; Gottschild D; Friess H
Liver Transpl; 2012 Jan; 18(1):53-61. PubMed ID: 21850692
[TBL] [Abstract][Full Text] [Related]
17. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
[TBL] [Abstract][Full Text] [Related]
18. Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
Lee JW; Paeng JC; Kang KW; Kwon HW; Suh KS; Chung JK; Lee MC; Lee DS
J Nucl Med; 2009 May; 50(5):682-7. PubMed ID: 19372474
[TBL] [Abstract][Full Text] [Related]
19. Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating
Yoh T; Seo S; Ogiso S; Kawai T; Okuda Y; Ishii T; Taura K; Higashi T; Nakamoto Y; Hatano E; Kaido T; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):542-549. PubMed ID: 29168098
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
